- £392.58m
- £468.78m
- £874.40m
- 33
- 60
- 43
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 1,447 | 638 | 1,506 | -843 | 874 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,350 | 613 | 1,477 | -781 | 873 |
Operating Profit | 96.1 | 24.6 | 28.8 | -62.1 | 1.8 |
Net Income Before Taxes | 96.1 | 24.6 | 28.8 | -62.1 | 1.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 79.1 | 21.2 | 27.3 | -33.7 | 18.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 79.1 | 21.2 | 27.3 | -33.7 | 18.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 79.1 | 21.2 | 27.3 | -33.7 | 18.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.523 | 0.296 | 0.181 | -0.291 | 0.095 |
Dividends per Share |